NUTX vs ASTH

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Oct 21, 2026

NUTX

47.5
AI Score
VS
ASTH Wins

ASTH

50.6
AI Score

Investment Advisor Scores

NUTX

48score
Recommendation
HOLD

ASTH

51score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric NUTX ASTH Winner
Forward P/E 0 8.9686 Tie
PEG Ratio 0 0 Tie
Revenue Growth -13.6% 48.5% ASTH
Earnings Growth 95.9% 110.5% ASTH
Tradestie Score 47.5/100 50.6/100 ASTH
Profit Margin 21.2% 1.1% NUTX
Beta 1.00 1.00 Tie
AI Recommendation HOLD HOLD Tie

Relative Price Performance (Last 90 Days)

NUTX 1M: +2.1% · 3M: +41.3% ASTH 1M: +10.7% · 3M: -5.7%

Current Technical Phase

NUTX

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (10.7% over 20 days), RSI 52

RSI (14): 52.3 · Price: $206.09

ASTH

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 54

RSI (14): 53.6 · Price: $38.01

Fundamentals Snapshot

Metric NUTX ASTH
Market Cap — —
Forward P/E 7.4 10.5
Trailing P/E 7.8 46.7
Revenue (TTM) — —
Revenue Growth -0.1% 0.5%
Gross Margin 0.5% 0.1%
Operating Margin 0.6% 0.0%
EPS 25.24 0.80
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, ASTH is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.